U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508501) titled 'Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets' on March 24.

Brief Summary: This study is a single-center, randomized, open-label, two-period crossover design to evaluate the effect of food on the pharmacokinetic profile of ammoxetine hydrochloride enteric-coated tablets.

Study Start Date: Feb. 08, 2023

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Ammoxetine hydrochloride enteric-coated tablets

Single-dose of 40mg of ammoxetine hydrochloride enteric-coated tablets

DRUG: Ammoxetine hydrochloride enteric-coated tablets

Single-dose of 40 mg of ammoxetine hydrochloride ent...